Resistance Training and Gut Health: Review Reveals Zonulin, Mucin, and Gut-Muscle Axis Connections Original paper

What was reviewed?

This rapid review systematically examined the existing literature on the relationship between resistance training and the human gut microbiome. The authors aimed to determine whether resistance or strength training independently modulates the gut microbiome’s composition, diversity, or functional capacity. Unlike previous reviews that focused on endurance exercise or mixed physical activity protocols, this review specifically isolated resistance training as the intervention of interest. The review synthesized evidence from human studies published between January 2010 and October 2022, indexed in PubMed, Scopus, and Web of Science. The primary outcomes assessed included changes in bacterial taxa composition, alpha and beta diversity, and secondary gut-related parameters such as zonulin levels, mucin production, short-chain fatty acid (SCFA) production, and fecal pH. The review also explored emerging concepts like the gut-muscle axis and its potential relevance to resistance training and gut microbiome interactions.

Who was reviewed?

The review included seven human studies that met strict eligibility criteria: (1) human subjects, (2) English-language research articles, and (3) experimental studies, randomized controlled trials, quasi-experimental studies, or observational/cohort designs. The study populations were diverse, encompassing healthy adults (including older adult males aged 51-78 years), healthy students (18-33 years), healthy sedentary elderly women (66-75 years), patients with cirrhosis, amateur bodybuilders (22-28 years), and comparative groups of bodybuilders versus endurance athletes versus sedentary individuals. Sample sizes ranged from 14 to 56 participants across intervention studies, with observational studies including up to 45 participants. The reviewed studies employed various resistance training protocols, with frequencies ranging from once weekly to three times weekly, and durations from 6 to 12 weeks. Methodological quality was assessed using appropriate tools: the modified Jadad Scale for randomized controlled trials, ROBINS-I for non-randomized interventions, and the JBI Critical Appraisal Checklist for cross-sectional studies.

Most important findings

The review’s most striking finding is that resistance training alone does not significantly alter gut microbiome composition or diversity, challenging assumptions that all forms of exercise positively modulate the microbiota. None of the seven included studies demonstrated significant changes in bacterial taxa composition or alpha/beta diversity following resistance training interventions. However, several important secondary findings emerged that have clinical relevance for resistance training and gut microbiome interactions.

The review highlights that while resistance training and gut microbiome composition show limited direct association, resistance exercise may beneficially influence gut health through non-compositional mechanisms. The decrease in zonulin—a protein regulating intestinal tight junctions—suggests resistance training may reduce intestinal permeability independent of microbial taxonomic shifts. This aligns with findings from combined aerobic/resistance training studies in type 2 diabetes patients showing reduced zonulin and Candida albicans. The observed increase in mucin biosynthesis further supports improved gut barrier integrity, as mucin proteins form the protective mucus layer separating host epithelium from luminal contents.

The gut-muscle axis emerged as a particularly compelling concept. Individuals achieving greater strength gains (higher 3RM squat) exhibited enriched butyrate-producing bacteria (Ruminococcus, Lachnospiraceae, Clostridium). Butyrate possesses potent anti-inflammatory properties, enhances intestinal barrier integrity, and may activate mTOR signaling pathways involved in muscle protein synthesis. This raises the possibility that a butyrate-producing microbiota supports optimal training adaptation, while dysbiosis (e.g., Proteobacteria enrichment in non-responding cirrhosis patients) may impair strength gains. The higher fecal pH observed in bodybuilders likely reflects proteolytic fermentation from high-protein diets, which may select for different microbial communities compared to carbohydrate-fueled endurance athletes.

Key implications

For clinicians working with athletes, aging populations, or patients with metabolic conditions, this review provides nuanced insights into resistance training and gut microbiome interactions. The most important clinical takeaway is that resistance training may benefit gut health through mechanisms independent of microbial composition changes—specifically by reducing intestinal permeability (lower zonulin) and enhancing mucosal barrier function (increased mucin). This suggests that prescribing resistance exercise could be valuable for patients with conditions associated with increased intestinal permeability, such as inflammatory bowel disease, metabolic syndrome, or autoimmune disorders, even if dramatic shifts in gut microbiota are not anticipated.

The gut-muscle axis findings have practical implications for exercise prescription. Patients who struggle to gain strength despite adequate resistance training may benefit from gut microbiome assessment and interventions targeting butyrate-producing bacteria (e.g., increased dietary fiber, prebiotics, or probiotic supplementation). The association between strength gains and butyrate producers suggests that gut health may be a modifiable factor influencing anabolic responses to training. For older adults at risk of sarcopenia, combining resistance training with gut-directed interventions could theoretically enhance muscle health outcomes.

The review also highlights important methodological considerations for clinicians interpreting gut microbiome studies. The lack of significant diversity changes may reflect inadequate training “doses” (frequency, volume, intensity) in the included studies, rather than true absence of effect. Most interventions used WHO minimum recommendations (2 sessions weekly), which may be insufficient to drive microbial changes. Additionally, the confounding effect of diet—particularly high-protein intakes in bodybuilders—cannot be overstated. Clinicians should view gut microbiome results in the context of patients’ overall dietary patterns, not just exercise habits.

Finally, this review underscores that resistance training and gut microbiome research remains in its infancy. The small number of studies, heterogeneous populations, and methodological disagreements prevent definitive conclusions. Clinicians should interpret these findings as hypothesis-generating and consider them alongside the well-established benefits of resistance training for muscle mass, bone density, metabolic health, and functional status. While awaiting more robust evidence, prescribing resistance training remains strongly supported for overall health, with the added possibility of gut-related benefits.